We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+18.27%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.08B
AUM Growth
+$89.3M
Cap. Flow
+$8.65M
Cap. Flow %
0.8%
Top 10 Hldgs %
53.14%
Holding
94
New
23
Increased
12
Reduced
34
Closed
20

Top Buys

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$34.7M
2
SCTL
Societal CDMO, Inc. Common Stock
SCTL
+$13.5M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$11.4M
4
GH icon
Guardant Health
GH
+$9.37M
5
SONX
Sonendo, Inc.
SONX
+$7.47M

Top Sells

Rank Stock Value
1
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
+$12.5M
2
MODN
MODEL N, INC.
MODN
+$12.3M
3
MIRM icon
Mirum Pharmaceuticals
MIRM
+$11M
4
CDNA icon
CareDx
CDNA
+$9.36M
5
CUTR
Cutera, Inc.
CUTR
+$8.94M

Sector Composition

Rank Sector Weight
1 Healthcare 86.01%
2 Communication Services 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MODN
1
DELISTED
MODEL N, INC.
MODN
$92.6M 8.59%
2,282,621
-325,600
-12% -$12.3M
PRTA icon
2
Prothena Corp
PRTA
$425M
$92.5M 8.59%
1,535,599
-3,079
-0.2% -$180K
RETA
3
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$78.4M 7.27%
2,062,453
+1,007,468
+95% +$34.7M
ATRC icon
4
AtriCure
ATRC
$1.92B
$64.5M 5.98%
1,452,514
-42,141
-3% -$1.76M
SPNE
5
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$57.4M 5.33%
6,877,650
-189,922
-3% -$1.28M
HALO icon
6
Halozyme
HALO
$9.79B
$52.5M 4.88%
923,119
-9,125
-1% -$467K
KRYS icon
7
Krystal Biotech
KRYS
$10.1B
$37.5M 3.48%
473,691
-18,864
-4% -$1.4M
ATEC icon
8
Alphatec Holdings
ATEC
$1.46B
$36.1M 3.35%
2,926,173
-48,485
-2% -$489K
KRTX
9
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$32.3M 3%
164,615
-1,701
-1% -$365K
SIBN icon
10
SI-BONE Inc
SIBN
$788M
$28.6M 2.66%
2,105,453
+77,490
+4% +$1.13M
KROS icon
11
Keros Therapeutics
KROS
$199M
$28.4M 2.64%
592,412
-5,801
-1% -$271K
PHLT
12
DELISTED
Performant Healthcare Inc
PHLT
$26.7M 2.48%
7,387,280
+2,367,173
+47% +$5.54M
TNDM icon
13
Tandem Diabetes Care
TNDM
$1.34B
$26.3M 2.45%
586,150
+100,530
+21% +$4.55M
CUTR
14
DELISTED
Cutera, Inc.
CUTR
$25.1M 2.33%
567,139
-196,041
-26% -$8.94M
NEO icon
15
NeoGenomics
NEO
$1.96B
$24.8M 2.3%
2,682,171
-37,928
-1% -$354K
CRNX icon
16
Crinetics Pharmaceuticals
CRNX
$8.84B
$24.3M 2.26%
1,329,313
-17,339
-1% -$306K
AXGN icon
17
Axogen
AXGN
$2.27B
$23.7M 2.2%
2,371,848
-539,976
-19% -$6M
FNA
18
DELISTED
Paragon 28, Inc.
FNA
$23.6M 2.19%
1,236,262
-1,793
-0.1% -$33.9K
KRMD icon
19
KORU Medical Systems
KRMD
$189M
$22.6M 2.1%
6,338,082
+64,309
+1% +$177K
BCYC
20
Bicycle Therapeutics
BCYC
$269M
$20.6M 1.91%
696,432
-8,289
-1% -$222K
PLRX icon
21
Pliant Therapeutics
PLRX
$64.4M
$20.4M 1.9%
1,057,881
+92,767
+10% +$1.94M
AXNX
22
DELISTED
Axonics, Inc. Common Stock
AXNX
$19.4M 1.8%
310,449
-6,360
-2% -$422K
BLU
23
DELISTED
BELLUS Health Inc.
BLU
$19.4M 1.8%
2,356,950
-24,907
-1% -$232K
OMCL icon
24
Omnicell
OMCL
$1.61B
$17.4M 1.61%
344,151
-4,955
-1% -$298K
TMDX icon
25
Transmedics
TMDX
$2.64B
$16.4M 1.52%
265,097
+111,328
+72% +$5.92M
1
2 3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, First Light Asset Management held 94 positions worth $1.08B, up 9% from $988M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

First Light Asset Management's Q4 2022 filing shows 23 new, 12 increased, 34 reduced and 20 closed positions. Its largest new stake was Societal CDMO, Inc. Common Stock: 8,571,870 shares worth $12.8M. The largest sale was NGM Biopharmaceuticals, Inc. Common Stock, an estimated $12.5M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 86% a quarter earlier, followed by Communication Services.

  • First Light Asset Management's largest Q4 2022 buy was Societal CDMO, Inc. Common Stock: 8,571,870 shares worth $12.8M.
  • First Light Asset Management added most to Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2022, an estimated $34.7M increase.
  • First Light Asset Management's biggest Q4 2022 reduction was MODEL N, INC., cutting an estimated $12.3M.
  • First Light Asset Management fully exited NGM Biopharmaceuticals, Inc. Common Stock in Q4 2022, selling an estimated $12.5M.
  • First Light Asset Management's ten largest holdings make up 53% of its $1.08B portfolio in Q4 2022.
  • First Light Asset Management opened 23 new positions and closed 20 in Q4 2022.
  • First Light Asset Management's portfolio value rose 9% quarter-over-quarter to $1.08B.

Based on First Light Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.